title: Characterization and development of UCI 107, a primary human ovarian carcinoma cell line.
abstract: We introduce a new epithelial ovarian carcinoma cell line (UCI 107) from a patient with papillary adenocarcinoma of the ovary who had not been previously treated. The growth characteristics, chemosensitivity, tumorgenicity, cytogenetics, antigen expression, and receptor status were examined. A standardized photometric assay was implemented to determine the response to single drug agents including doxorubicin (ADR), cisplatin (CDDP), and Taxol. Tumorgenicity was determined utilizing female athymic mice implanted either subcutaneously (sc) or intraperitoneally (ip) with 1 x 10(7) UCI 107 cells. UCI 107 cells grow rapidly in culture with lag phase of approximately 48 hr, population doubling time of 24-36 hr, and saturation density of 4.8 x 10(5) cells/cm2. The 50% inhibitory concentration values for the chemotherapeutic agents were 0.170, 0.029, and 0.330 microM for ADR, Taxol, and CDDP, respectively. Nude mice produced ip tumors within 15 days, resulting in death from carcinomatosis 40-45 days postimplantation. Subcutaneous tumor nodules (100 mm3) were observed in nude mice 12-13 days post-tumor implantation reaching a maximum tumor volume of approximately 10,000 mm3 by Day 30. The cytogenetic composite karyotype is as follows: 46, X, der (X) t (X;7) (p11;q22), inv dup (1) (q12;q32), t (6;6;11;22) (p21.3;q16;q23.3;q13.3), del (13) (q14.1). The cell line expresses progesterone receptor, increased levels of p53 protein, and cytokeratins. It does not appear to express Her-2/neu protein, estrogen receptor, nor the CA 125 tumor marker. In conclusion, UCI 107 displays unique cellular properties which make it an attractive model for the study of ovarian cancer.
authors.affiliation: Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange 92668, USA.
authors.forename: G
authors.initials: G
authors.lastname: Gamboa
authors.forename: P M
authors.initials: PM
authors.lastname: Carpenter
authors.forename: Y D
authors.initials: YD
authors.lastname: Podnos
authors.forename: G
authors.initials: G
authors.lastname: Dorion
authors.forename: L
authors.initials: L
authors.lastname: Iravani
authors.forename: D
authors.initials: D
authors.lastname: Bolton
authors.forename: J T
authors.initials: JT
authors.lastname: Mascarello
authors.forename: A
authors.initials: A
authors.lastname: Manetta
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000378:metabolism; D002277:Carcinoma / Q000235:genetics / Q000473:pathology*; D002455:Cell Division; D002874:Chromosome Mapping; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology*; D011956:Receptors, Cell Surface / Q000378:metabolism; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: D000951:Antigens, Neoplasm; D011956:Receptors, Cell Surface